A report on the experiences of 13 patients found that the drug had no benefit for some and that some who benefited said the ...

These findings counter clinical trial results published in June which found that Paxlovid was safe to take but did not lessen ...

These companies headline a $1.4 trillion industry, have staying power, and will pay you well to hold their stock.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

A widely available antiviral medication offers new possibilities for long Covid patients seeking relief from debilitating symptoms. Research shows extended Paxlovid treatment could help restore ...

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

Pfizer CEO highlights savings, leadership changes, and acquisition-driven growth amid significant revenue loss challenges ...

A detailed examination of how patients respond to the drug at various times and doses provides greater context to a recent ...

Brookstone Capital Management trimmed its stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 11.9% in the fourth ...

At the JPM conference, Pfizer CEO Albert Bourla projected optimism, saying the market was overlooking the pharma company's ...

Federal science agencies have renewed and increased funding for a world-renowned digital archive of protein structures housed ...

In the winter months, it seems few are safe from some kind of illness — flu, COVID-19, norovirus, colds, and that’s definitely the case right now for Georgia and South Carolina.